Gold Award recognizes the FDA approval of a study into the effectiveness of the SynCardia Total Artificial Heart powered by the Freedom® portable driver for end-stage biventricular heart failure patients who don’t qualify for donor heart transplants.Continue reading→

“SynCardia Systems, a developer and manufacturer of temporary implantable artificial hearts, filed on Monday with the SEC to raise up to $40 million in an initial public offering.”  (Source) Continue reading→

Blackstone Ventures Inc.  (TSX VENTURE:BLV)  has entered into a letter of intent, subject to receipt of all applicable regulatory and shareholder approvals, to acquire Lattice Biologics Inc.Continue reading→

SCIENCE FOUNDATION ARIZONA, INTEL ANNOUNCE CODE WRITERS EDUCATION INITIATIVE

Continue reading→

Rapid, accurate test for coccidioidomycosis developed by TGen’s Pathogen Genomics Division to accelerate patient careContinue reading→

PHOENIX — A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute’s Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.Continue reading→

University of Arizona Cancer Center at St. Joseph’s Hospital Set To OpenContinue reading→

New technology addresses the most common global cause of bacterial food-borne illness Continue reading→

This summer more than 100 select Arizona youth participated in unique summer programs at the University of Arizona College of Medicine – Phoenix. Opportunities such as the college’s Department of Basic Medical Sciences’ High School Research Internship program and Summer Scrubs provided local adolescents with the chance to work alongside biomedical experts and develop greater interest in pursuing a future career in health care.Continue reading→